It is well understood that corals harbor diverse microbial communities. Recently, many coral-associated bacteria have been characterized as sources of marine natural products, especially as the coral surface is more nutrient rich than seawater or even sediments.1, 2 Colonization of coral surfaces by bacteria and other microorganisms is mostly nondestructive to corals. Owing to the close spatial vicinity of these biofilm-forming bacteria, it can be expected that the indigenous microbial population is adapted to competitive conditions.3 The production of secondary metabolites is a common adaptation of these bacteria to compete in such microenvironments. There have been few reports documented on exploration of coral-associated bacteria in the South China Sea as a source of secondary metabolites.
In order to obtain biologically active natural products from coral-associated bacteria, we studied the marine bacterium Bacillus amyloliquefaciens SCSIO 00856 isolated from the South China Sea gorgonian Junceella juncea. In the preliminary experiments, we found that the culture broth of the strain had strong antibacterial activity towards three bacteria (Escherichia coli, Bacillus subtilis, and Staphyloccocus aureus) and antilarval activity towards laboratory-reared bryozoan Bugula neritina larvae. In this study, a new 24-membered ring lactone, macrolactin V (1) (Figure 1), together with four known compounds, macrolactin S (2),4 4-butoxyphenol (3),5 4-propoxyphenol (4),6 and 4-ethoxyphenol (5),6 was isolated from a culture broth of the strain. Macrolactins are polyene macrolides containing a 24-membered lactone ring. About 20 macrolactins have been chemically characterized, including macrolactins A-U, 7-O-succinyl macrolactin A, and 7-O-succinyl macrolactin F, from marine Bacillus sp. sediment isolate, and 7-O-malonyl macrolactin A from Bacillus subtilis soil isolate.4, 7, 8, 9, 10, 11, 12, 13 Some of these compounds showed strong antibacterial, anti-tumor, and antivirus activities.4, 7, 9, 10, 11, 12, 13 The antibacterial activity of 1–5 against four bacterial strains and the antilarval activity of 3–5 against larval settlement of Bugula neritina and Balanus amphitrite larvae were evaluated. This paper deals with the isolation, structural elucidation of 1 and biological activity of 1–5.
The producing strain, Bacillus amyloliquefaciens SCSIO 00856, was isolated from the gorgonian coral Junceella juncea in Sanya, Hainan province, China. The strain culture (2 ml) was used to inoculate 50 ml seed medium consisting of 0.4% yeast extract, 0.4% glucose, 0.5% malt meal, and 1.8% sea salt (pH 7.3), in a 250-ml flask. A volume of 20 ml of the resulting culture was used to inoculate 400 ml of the seed medium, in a 1-l flask. The culture was incubated at 27 °C on a rotary shaker operating at 150 r.p.m. for 5 days. The resulting 400-ml culture was used to inoculate 120 l of production medium, in a 200-l fermenter, containing the following components per liter of water: yeast extract 4 g, malt meal 5 g, glucose 4 g, and sea salt 18 g. The production fermentation tanks were operated at 27 °C, a back-pressure of 0.1 MPa, and an agitation rate of 150 r.p.m. pH was controlled at 7.3 by addition of NaOH. The fermenter was operated for 10 days, at which time the culture was harvested for isolation of metabolites. The culture broth (120 l) was extracted with EtOAc. The EtOAc extract was concentrated in vacuo to afford 13.9 g of residue, which was subjected to column chromatography (CC) on silica gel, using CHCl3-MeOH (from 10:0 to 0:10) as eluent. Elution of CC with 8% MeOH in CHCl3 gave a fraction of 835 mg. The fraction was subsequently subjected to CC on silica gel, eluted with CHCl3-MeOH, then purified with semi-preparative HPLC (Luna C18(2), 250 × 10 mm i.d., 5 ml min−1), using MeOH-water (65:35) as eluent to yield 1 (2.6 mg) and 2 (19.7 mg). Elution of the first CC with 20% MeOH in CHCl3 gave a 342-mg fraction, which was rechromatographed on a silica gel column using a gradient elution of CHCl3-MeOH to yield 3 (60 mg). The fraction (163 mg) eluted with 35% MeOH in CHCl3 at the first CC was repeatedly subjected to silica gel column using a gradient elution of CHCl3-MeOH to yield 4 (7.5 mg) and 5 (7.0 mg). The structures of 3–5 were established by analyzing their 1D NMR spectral data and by comparison with the literature.5, 6
Compound 1 had the molecular formula of C24H34O6 as deduced from NMR spectra and HR-ESI-MS. The 1H NMR spectrum showed signals for one methyl group at δH 1.25 (3H, d, J=6.0 Hz), 12 olefinic protons and five oxymethine protons at the chemical shift downfield of δH 4.03–7.25 (Table 1). Its 13C NMR spectrum showed the presence of one methyl, five methylenes, six 1,2-disubstituted double bonds, five oxymethines, and a carbonyl group (δC 167.8) (Table 1). These 1H and 13C NMR data of 1 were very similar to those of macrolactin S (2)4 (Table 1). Extensive analyses of the 1H NMR, 13C NMR, HSQC, HMBC (Figure 2), and 1H–1H COSY spectra of 1 inferred that 1 should have the same chemical planar structure as 2. In the 1H NMR spectrum of 1, the 1H coupling constants of H-2/H-3 (J=11.5 Hz), H-4/H-5 (J=15.0 Hz), H-8/H-9 (J=15.0 Hz), H-10/H-11 (J=10.0 Hz), H-16/H-17 (J=15.0 Hz), and H-18/H-19 (J=15.0 Hz) indicated that geometric configurations of 1 were 2Z,4E,8E,10Z,16E,18E. The 1H and 13C NMR data of H-12/C-12, H-13/C-13, H-15/C-15, and H-23/C-23 in 1 were almost the same as those in 2, which suggested that the stereochemistry of chiral carbons C-12, C-13, C-15, and C-23 was the same as that in 2.
However, compared with the 1H and 13C NMR data of 2, the downfield shift of H-6 (from δH 2.47 in 2 to δH 2.57 in 1), H-7 (from δH 4.18 to δH 5.38), C-7 (from δC 73.6 to δC 75.7), and C-9 (from δC 127.4 to δC 130.0), and upfield shift of C-5 (from δC 142.1 to δC 140.3) and C-6 (from δC 42.6 to δC 39.7) were obviously observed in the NMR spectra of 1, which should be caused by the change of the three-dimensional effect at C-7 position, and suggested that the configuration of −OH at C-7 in 1 should be α-configuration instead of β-configuration as it existed in 2 and other previously isolated macrolactins.4, 7, 8, 9, 10, 11, 12, 13 The suggestion was supported by the NOESY (Figure 3), in which NOE correlations of H-6β with H-8/H-4 and H-7 with H-8 were observed, whereas no NOE correlations between H-7 and H-9/H-5 were observed, which were in agreement with the MM2 optimized conformation of 1. However, NOE correlations of H-7 with H-9/H-5 were obviously observed in the NOESY of 2.4 Thus, the structure of 1 was determined as shown and named macrolactin V. The optical rotation value of 1 is −0.08 (c 0.11, MeOH), which is different from that of 2 (−0.62 (c 0.15, MeOH)).4
The antibacterial activity of compounds 1–5 was measured against E. coli, Bacillus thuringiensis, Bacillus subtilis, and S. aureus using standard disc diffusion assay.14 The MICs of compound 1–5 were determined by a dilution method.15 The results showed that macrolactin V (1) had strong antibacterial activity against E. coli, Bacillus subtilis, and S. aureus, with an MIC value of 0.1 μg ml−1, and no activity against Bacillus thuringiensis, and macrolactin S (2) showed strong antibacterial activity against E. coli and S. aureus with MIC values of 0.3 and 0.1 μg ml−1, respectively, but weak activity against Bacillus subtilis (MIC 100 μg ml−1), which indicated that the configuration of OH-7 could affect the antibacterial activity of the epimers 1 and 2. Compounds 3–5 showed no or weak inhibition towards all tested bacteria.
The antilarval activity of compounds 3–5 was evaluated in settlement inhibition assays with laboratory-reared Bugula neritina (Bryozoa) and Balanus amphitrite (Cirripedia) larvae. The procedures were the same as previously reported.16 Larval settlement bioassays revealed that 3–5 showed potent antilarval activity towards Bacillus amphitrite larvae with EC50 values of 23.0, 22.9, and 24.1 μg ml−1, respectively. However, only 3 could inhibit Bacillus neritina larvae settlement at the concentration of 50 μg ml−1, but no activity at 25 μg ml−1, and 4 and 5 were inactive even at 50 μg ml−1. The EC50 values of 3–5 against Bacillus amphitrite larvae settlement were lower than the standard requirement of an EC50 of 25 μg ml−1 established by the US Navy program as an efficacy level for natural antifoulants, indicating that 3–5 are potential selective natural antifouling agents. This was the first time to report 3–5 from culture broths of bacteria and their antilarval activities against marine invertebrate larvae.
Experimental procedure
Taxonomy
Blast search results at EzTaxon.org Server showed that the 16S rRNA gene sequence of the strain SCSIO 00856 has the highest similarity (99.21%) with Bacillus amyloliquefaciens ATCC 23350T. On the basis of the morphological features and the 16S rRNA gene sequence, the strain SCSIO 00856 was identified as Bacillus amyloliquefaciens and named Bacillus amyloliquefaciens SCSIO 00856. It was deposited at the Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, The Chinese Academy of Sciences, China (Accession No. SCSIO 00856).
Physico-chemical properties
Macrolactin V: yellow oil; [α]D20 −0.08° (c 0.11, MeOH), UV (MeOH) λmax (log ɛ) 229 (4.57), 261 (4.18) nm; IR (KBr): 3295, 1700, 1667 cm−1; for 1H and 13C NMR data, see Table 1; HR-ESI-MS m/z: [M+H]+ 419.2357 (calcd. for C24H35O6: 419.2355).
References
Moore, B. S. Biosynthesis of marine natural products-microorganisms and macroalage. Nat. Prod. Rep. 16, 653–674 (1999).
Radjasa, O. K. Marine invertebrate-associated bacteria in coral reef ecosystems as a new source of bioactive compounds. J. Coast. Dev. 7, 65–70 (2004).
Slattery, M., Rajbhandari, I. & Wesson, K. Competition-mediated antibiotic induction in themarine bacterium Streptomyces tenjimariensis. Microb. Ecol. 41, 90–96 (2001).
Lu, X. L. et al. Macrolactin S, a novel macrolactin antibiotic from marine Bacillus sp. Nat. Prod. Res. 22, 342–347 (2008).
Green, J., Marcinkiewicz, S. & McHale, D. Paper chromatography and chemical structure. III. The correlation of complex and simple molecules. The calculation of RM values for tocopherols, vitamins K, ubiquinones, and ubichromenols from RM (phenol). Effects of unsaturation and chain branching. J. Chromatogr. 10, 158–183 (1963).
Gouws, S., Barton, B., Loyson, P. L. R. & Zeelie, B. Electrochemical production of alkoxy-substituted phenols. Electrochim. Acta 53, 4544–4549 (2008).
Gustafson, K., Roman, M. & Fenical, W. The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium. J. Am. Chem. Soc. 111, 7519–7524 (1989).
Rychnovsky, S. D., Skalitzky, D. J., Pathirana, C., Jensen, P. R. & Fenical, W. J. Stereochemistry of the macrolactins. J. Am. Chem. Soc. 114, 671–677 (1992).
Nagao, T., Adachi, K., Sakai, M., Nishijima, M. & Sano, H. Novel macrolactins as antibiotic lactones from a marine bacterium. J. Antibiot. 54, 333–339 (2001).
Yoo, J. S., Zheng, C. J., Lee, S., Kwak, J. H. & Kim, W. G. Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis. Bioorg. Med. Chem. Lett. 16, 4889–4892 (2006).
Jaruchoktaweecha, C., Suwanborirux, K., Tanasupawatt, S., Kittakoop, P. & Menasveta, P. New macrolactins from a marine Bacillus sp. Sc026. J. Nat. Prod. 63, 984–986 (2000).
Taharez, M. R. et al. 7-O-Malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, and a small-colony variant of Burkholderia cepacia. Antimicrob. Agents Chemother. 50, 1701–1709 (2006).
Xue, C. M., Tian, L., Xu, M. J., Deng, Z. W. & Lin, W. H. A new 24-membered lactones and a new polyene δ-lactone from the marine bacterium Bacillus marinus. J. Antibiot. 61, 668–674 (2008).
Acar, J. F. The disc susceptibility test. in Antibiotics in Laboratory Medicine (ed. Lorian, V.) 24–54 (Williams & Wilkins, Baltimore, 1980).
Brantner, A. & Grein, E. Antibacterial activity of plant extracts used externally in traditional medicine. J. Ethnopharmacol. 44, 35–40 (1994).
Qi, S. H., Zhang, S., Qian, P. Y. & Wang, B. G. Antifeedent, antibacterial, and antilarval compounds from the South China Sea seagrass Enhalusacroroides. Bot. Marina. 51, 441–447 (2008).
Acknowledgements
We are grateful to the Knowledge Innovation Program of the Chinese Academy of Science (grant KZCX2–YW–216-1), the National Basic Research Program of China (grant 2010CB833800-G), the National Natural Science Foundation of China and Research Grants Council of Hong Kong (NSFC/RGC) Program (grant 40910093), and the Knowledge Innovation Program of the South China Sea Institute of Oceanology, Chinese Academy of Sciences (grant LYQY200703) for financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gao, CH., Tian, XP., Qi, SH. et al. Antibacterial and antilarval compounds from marine gorgonian-associated bacterium Bacillus amyloliquefaciens SCSIO 00856. J Antibiot 63, 191–193 (2010). https://doi.org/10.1038/ja.2010.7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ja.2010.7
Keywords
This article is cited by
-
In vitro and in vivo antibacterial activity of sea anemone-isolated Vibrio parahaemolyticus against Yersinia ruckeri
Aquaculture International (2022)
-
Moving away from traditional antibiotic treatment: can macrocyclic lactones from marine macroalga-associated heterotroph be the alternatives?
Applied Microbiology and Biotechnology (2020)
-
Natural product diversity of actinobacteria in the Atacama Desert
Antonie van Leeuwenhoek (2018)
-
Antifouling potentials of eight deep-sea-derived fungi from the South China Sea
Journal of Industrial Microbiology and Biotechnology (2014)
-
Bacterial Communities of the Gorgonian Octocoral Pseudopterogorgia elisabethae
Microbial Ecology (2013)